| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |